One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but that some tumors give them too little to see. New research from Dana-Farber Cancer Institute scientists reveals how cancers ...
Sep 17, 2026
0
8
Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives innovations that revolutionize cancer ...
Sep 17, 2026
0
9
Redness and pain at the injection site, fever, fatigue or headaches: Vaccines can cause side effects, but their frequency and severity vary considerably from person to person. Why?
Sep 17, 2026
0
7
Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the other, the treatment does nothing. Oncologists still have no reliable way to tell these patients ...
Sep 16, 2026
0
7
Researchers at DZNE and Charité—Universitätsmedizin Berlin are working on a targeted therapy for neurological autoimmune diseases. So far, they have successfully tested their approach in mouse studies involving two such conditions. ...
Sep 16, 2026
0
10
A new study illuminates the connection between the Epstein-Barr virus (EBV) and multiple sclerosis (MS), pointing to a causal role for reactivation of the virus in triggering MS attacks in people with certain genetic risk ...
Sep 16, 2026
0
21
When it comes to priorities in life, oxygen tops the list. Humans can go weeks without food and days without water. Take away the ability to breathe, however, and the clock starts ticking within minutes as the brain begins ...
Sep 15, 2026
0
19
A research team led by Professor Zhou Xuyu from the Institute of Microbiology of the Chinese Academy of Sciences (CAS), in collaboration with researchers from Beijing Ditan Hospital and Capital Medical University, has identified ...
Sep 14, 2026
0
6
A scientific team has developed a laboratory model that reveals how antibody-producing plasma cells migrate, mature and survive within human bone marrow, a main location of long-lived antibody-producing plasma cells. The ...
Sep 14, 2026
1
32
Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anticancer immune response.
Sep 11, 2026
0
48
